Bristol-Myers Squibb agrees to pay $670 million to settle several lawsuits. The suits accused the pharmaceutical company of fraudulently restricting competitors from selling cheap copies of two of its best-selling drugs. NPR's Snigdha Prakash reports.
Copyright 2003 NPR
This news story is funded in large part by Connecticut Public’s Members — listeners, viewers, and readers like you who value fact-based journalism and trustworthy information.
We hope their support inspires you to donate so that we can continue telling stories that inform, educate, and inspire you and your neighbors. As a community-supported public media service, Connecticut Public has relied on donor support for more than 50 years.
Your donation today will allow us to continue this work on your behalf. Give today at any amount and join the 50,000 members who are building a better—and more civil—Connecticut to live, work, and play.
